Magnera
MAGNNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $13.05 Prior regular-session close from the quote source.
- $12.88–$13.28 Regular-session low and high so far today.
- 517.8K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Nov 18 projected Projected for 2026-11-18 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $7.82–$15.52 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own MAGN if Magnera is a levered specialty-materials turnaround whose value depends on proving that the combined organic-and-synthetic materials platform can convert a much larger revenue base into durable operating cash flow, not just bigger sales.
MAGN price history
Loading recent earnings…
Investment thesis
What must happen next
Large customers continue to value Magnera’s broad specialty-materials portfolio enough to keep the company specified into products rather than shifting volume to alternative substrates or rival suppliers.HoldingMateriality: High
Item 1 description identifies Magnera as a leading global supplier of a diverse portfolio of innovative specialty materials made from organic and synthetic raw ingredients. If customer relevance holds, the enlarged platform has a revenue base over which synergies can work; if it breaks, cost savings will be overwhelmed by lost volume and weaker mix.
Watch: Major hygiene, wipes, filtration, or industrial customers requalify products away from Magnera toward Ahlstrom, Freudenberg, Fitesa, Suominen, or in-house/private-label alternatives.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Item 1 description identifies Magnera as a leading global supplier of a diverse portfolio of innovative specialty materials made from.
Open source ↗The enlarged manufacturing footprint produces real operating leverage through procurement savings, plant utilization, mix management, and integration execution rather than simply adding low-margin sales.WeakeningMateriality: High
FY2025 annual GAAP operating income was $5 million, improving from a FY2024 annual GAAP operating loss of $141 million. This is the core equity value driver: sales scale only matters if it turns into structurally higher operating income.
Watch: Resin, pulp, energy, or freight inflation returns faster than Magnera can pass costs through customer contracts.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP operating income was $5 million, improving from a FY2024 annual GAAP operating loss of $141 million.
Open source ↗Magnera’s contracts, working-capital discipline, and operating execution keep the business cash-generative during the turnaround, so growth and integration do not consume cash.HoldingMateriality: Medium
FY2025 annual GAAP operating cash flow was positive at $103 million despite a FY2025 annual GAAP net loss of $159 million. Positive operating cash flow funds debt service and reinvestment; weak cash conversion would force asset sales, borrowing, or dilution.
Watch: Customer destocking or slower collections creates a receivables and inventory build that absorbs cash before reported sales decline.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP operating cash flow was positive at $103 million despite a FY2025 annual GAAP net loss of $159.
Open source ↗The post-combination balance sheet must be de-risked through internally generated cash so leverage does not constrain customer service, capital spending, or refinancing flexibility.WeakeningMateriality: Medium
FY2025 liabilities were $2.925 billion, up from FY2024 liabilities of $1.315 billion, indicating a much larger financial obligation base after the company’s transformation. If liabilities remain heavy relative to cash generation, equity holders may not capture the operating recovery even if the business improves.
Watch: Creditors require costly refinancing, tighter covenants, or asset pledges before the operating turnaround is complete.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 liabilities were $2.925 billion, up from FY2024 liabilities of $1.315 billion, indicating a much larger financial obligation base after.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Large customers continue to value Magnera’s broad specialty-materials portfolio enough to keep the company specified into products rather than shifting volume to alternative substrates or rival suppliers. If customer relevance holds, the enlarged platform has a revenue base over which synergies can work; if it breaks, cost savings will be overwhelmed by lost volume and weaker mix.
The enlarged manufacturing footprint produces real operating leverage through procurement savings, plant utilization, mix management, and integration execution rather than simply adding low-margin sales. This is the core equity value driver: sales scale only matters if it turns into structurally higher operating income.
Magnera’s contracts, working-capital discipline, and operating execution keep the business cash-generative during the turnaround, so growth and integration do not consume cash. Positive operating cash flow funds debt service and reinvestment; weak cash conversion would force asset sales, borrowing, or dilution.
The post-combination balance sheet must be de-risked through internally generated cash so leverage does not constrain customer service, capital spending, or refinancing flexibility. If liabilities remain heavy relative to cash generation, equity holders may not capture the operating recovery even if the business improves.
All standing thesis claims
Original report summary
Magnera is a levered specialty-materials turnaround whose value depends on proving that the combined organic-and-synthetic materials platform can convert a much larger revenue base into durable operating cash flow, not just bigger sales.
Bull case and bear case
Bull case and bear case for Magnera
Where the evidence on Magnera disagrees: Mixed on the latest evidence (Nov 7, 2026). Of its 4 thesis points, 2 holding and 2 weakening.
Bull case: what the evidence supports
Large customers continue to value Magnera’s broad specialty-materials portfolio enough to keep the company specified into products rather than shifting volume to alternative substrates or rival suppliers.
Magnera’s contracts, working-capital discipline, and operating execution keep the business cash-generative during the turnaround, so growth and integration do not consume cash.
Bear case: what the evidence questions
The enlarged manufacturing footprint produces real operating leverage through procurement savings, plant utilization, mix management, and integration execution rather than simply adding low-margin sales.
The post-combination balance sheet must be de-risked through internally generated cash so leverage does not constrain customer service, capital spending, or refinancing flexibility.
Thesis-Break Engine
Thesis-break watch · Magnera
No break has crossed Magnera’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Magnera filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Magnera filed an SEC 8-K on 2026-05-07: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Major hygiene, wipes, filtration, or industrial customers requalify products away from Magnera toward Ahlstrom, Freudenberg, Fitesa, Suominen, or in-house/private-label alternatives.
- Resin, pulp, energy, or freight inflation returns faster than Magnera can pass costs through customer contracts.
- Customer destocking or slower collections creates a receivables and inventory build that absorbs cash before reported sales decline.
- Creditors require costly refinancing, tighter covenants, or asset pledges before the operating turnaround is complete.
MAGN news
Loading headlines…
Financial statements
MAGN income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MAGN: quick answers
- When does Magnera (MAGN) report earnings next?
- Magnera's next results are projected for November 18, 2026, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on August 6, 2026. Earnings calendar
- What is MAGN's short interest?
- As of October 30, 2026, 2.0M MAGN shares were sold short, 5.72% of its shares outstanding, up 13.6% from the count before. At the stock's average daily volume that is 6.0 days to cover. FINRA publishes the count twice a month. MAGN short interest history
- Have members of Congress traded MAGN?
- 1 trade in MAGN has been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed MAGN trade